Literature DB >> 3810712

Familial hyperlipidemia in stroke in the young.

B C Bansal, A K Sood, C B Bansal.   

Abstract

Serum cholesterol, low density lipoproteins (LDL), very low density lipoproteins (VLDL) and chylomicron levels were studied in 25 young patients (age 40 years or less) of non-embolic ischemic stroke of unknown aetiology. Fifteen patients were males and 10 were females. The prevalence of hyperlipidemia was found to be 60%. Frederickson's type IIb hyperlipoproteinemia was the commonest (32%) abnormal pattern observed, followed by type IIa (12%), type IV (12%) and type V (4%). Family studies were carried out in all the 25 index patients (15 hyperlipidemic and 10 normolipidemic). Familial hyperlipidemia (i.e. 2 or more hyperlipidemic members in the same family) was found in 9 of the 15 hyperlipidemic index patients and in none of the normolipidemic index patients. The common pattern was found to be that of familial combined hyperlipidemia. The study indicates that screening the family members of hyperlipidemic young patients of non-embolic ischemic stroke may delineate a group of high risk individuals for possible primary prevention before they develop the disease.

Entities:  

Mesh:

Year:  1986        PMID: 3810712     DOI: 10.1161/01.str.17.6.1142

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  3 in total

1.  Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance.

Authors:  M Castro Cabezas; T W de Bruin; H W de Valk; C C Shoulders; H Jansen; D Willem Erkelens
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

2.  Stroke in young in India.

Authors:  Manjari Tripathi; Deepti Vibha
Journal:  Stroke Res Treat       Date:  2010-12-16

3.  High Prevalence of Cerebral Small Vessel Disease on 7T Magnetic Resonance Imaging in Familial Hypercholesterolemia.

Authors:  Yusuke Todate; Ikuko Uwano; Satoshi Yashiro; Ai Chida; Yutaka Hasegawa; Tomoyasu Oda; Kan Nagasawa; Hiroyuki Honma; Makoto Sasaki; Yasushi Ishigaki
Journal:  J Atheroscler Thromb       Date:  2019-03-15       Impact factor: 4.928

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.